Pulmonary Drug Delivery Systems Market to Benefit from Growing Prevalence of COPD and Asthma

global pulmonary drug delivery systems market is currently growing due to the increased prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma.

The research study cites a report by the World Health Organization which says that there are currently 300 million people around the world who suffer from asthma and 210 million who suffer from COPD. The WHO also wrote that changing lifestyles and a growing habit of smoking tobacco are the prime causes of the heavy increase in respiratory diseases.The global pulmonary drug delivery systems market is divided into three major segments according to products: nebulizers, dry powder inhalers, and metered dose inhalers. The 2012 global pulmonary drug delivery systems market was dominated by metered dose inhalers, which held 56.8% of the market share. This segment was followed by dry powder inhalers.